Clinical Trial Update: Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/3 trial evaluating atorvastatin for reno-protective effects during cardiopulmonary bypass has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Austin Health | Conditions: Acute Kidney Dysfunction | Phase 2, Phase 3 | Status: COMPLETED